Synthesis of ring-halogenated histidines and histamines

Tetrahedron

Volumn 54, Issue 13, 1998, Pages 3235-3242

  Jain, Rahul ^a,b   Avramovitch, Bianca ^a   Cohen, Louis A ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE; HISTIDINE;

ARTICLE; CHEMICAL REACTION KINETICS; DEHALOGENATION; DRUG SYNTHESIS; HALOGENATION; HISTAMINE RELEASE; PRIORITY JOURNAL; REACTION ANALYSIS; STRUCTURE ANALYSIS;

EID: 0032568383     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4020(98)00068-4     Document Type: Article

References (24)

1. 1. For a preliminary report of part of this work, see Book of Abstract; 208th National Meeting of the American Chemical Society; Washington DC, Aug. 1994; MED 23.
2. 2. For the sake of simplicity in numbering, only one of the two possible tautomers is considered.
3. 3. For example, (a) Perglut, L. E.; Wainio, W. W. Biochemistry, 1966, 5, 608;
4. (b) Perglut, L. E.; Wainio, W. W. Biochemistry, 1967, 6, 15-18;
5. (c) Holloway, C. T.; Bond, R. P.; Knight, I. G.; Beechey, R.B. Biochemistry, 1967, 6, 19-25.
6. 4. Faden, A. I.; Labroo, V. M.; Cohen, L. A. J. Neurotrauma 1993, 10, 101-108; Vanhof, S.; Paakkari, I.; Feuerstein, G.; Cohen, L. A.; Labroo, V. M. Eur. J. Pharmacol. 1989, 164, 77-83.
7. 4. Faden, A. I.; Labroo, V. M.; Cohen, L. A. J. Neurotrauma 1993, 10, 101-108; Vanhof, S.; Paakkari, I.; Feuerstein, G.; Cohen, L. A.; Labroo, V. M. Eur. J. Pharmacol. 1989, 164, 77-83.
8. 5. (a) Paton, L. J.; Rossan, R. N.; Escajadillo, A.; Matsumoto, Y.; Lee, A. T.; Labroo, V. M.; Kirk, K. L.; Cohen, L. A.; Aikawa, M.; Howard, R. J. Antimicrobial Agents Chemother. 1988, 32, 1655-1659;
9. (b) Howard, R. J.; Andrutis, A. T.; Leech, J. H.; Ellis, W. Y.; Cohen, L. A.; Kirk, K. L. Biochem. Pharmacol. 1986, 35, 1589-1596.
10. 6. Brunings, K. J. J. Am. Chem. Soc., 1947, 69, 205-208.
11. 7. (a) Wang, J.; Zhang, Z.; Liu, R.; Li, X. Huaxue Shiji 1996, 18, 184-185;
12. (b) Miyashita, M.; Seyama, Y.; Kaji, K.; Yamashita, S. Chem. Pharm. Bull., 1983, 31, 386-393;
13. (c) Slaunwhite, W. R., Jr. US Patent 4358435, 1982, 7pp, CA, 98, 68468;
14. (d) Tominaga, M.; Paiva, A. C. M. J. Med. Chem. 1969, 12, 693.
15. 8. Miyashita, M.; Yamashita, S. J. Chromatogr. 1989, 475, 135-144.
16. 9. (a) Bey, P.; Jung, M. US Patent 4388466, 1983, 13pp;
17. (b) Metcalf, B.W.; Jung, M. US Patent 4103089, 1978, 14pp, CA, 90, 152611.
18. 10. Only chloro, bromo and iodo derivatives are described. Synthesis of fluoro derivatives is a separate topic.
19. 11. Jain, R.; Cohen, L. A. Tetrahedron, 1996, 52, 5363-5370.
20. 12. Jain, R.; Cohen, L. A.; El-Kadi, N. A.; King, M. M. Tetrahedron, 1997, 53, 2365-2370.
21. 13. Jain, R.; Cohen, L. A.; King, M. M. Tetrahedron, 1997, 53, 4539-4548.
22. 14. Ito, S. J. Org. Chem. 1985, 50, 3636-3638.
23. 15. Schmir, G. L.; Cohen, L. A. Biochemistry, 1965, 4, 533-538.
24. 16. Takeuchi, Y.; Kirk, K. L.; Cohen, L. A. J. Org. Chem. 1979, 44, 4240-4242.